Loading…
Sectoral / Thematic · Nippon India Mutual Fund · AMFI code 102431Nippon India Pharma Fund
Disclosed for 84 months, Sep 2019 to Aug 2026.Published as: NIPPON INDIA PHARMA FUND (An Open Ended Equity Scheme Investing In Pharma Sector)
Portfolio value
₹8,357 Cr
down ₹380 Cr vs Jul 2025
- Stocks held
- 37
- unchanged
- Top 10 weight
- 56.4%
- of the portfolio in its ten largest
- Cash & debt
- 0.5%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 8, trimmed 29
Nippon India Pharma Fund is an active equity fund in the Sectoral / Thematic category from Nippon India Mutual Fund. In August 2025 it disclosed 37 stocks worth ₹8,357 Cr, down ₹380 Cr from Jul 2025. Its largest positions were Sun Pharmaceutical Industries Limited (11.9%), Divi's Laboratories Limited (7.3%), Cipla Limited (6.1%); the ten largest together made up 56.4% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 75.5% of its equity. Cash and debt stood at 0.5%. Compared with Jul 2025 the fund entered 0 new stocks and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
75%
Top-10 weight is higher than 75% of peers
Breadth
34%
Holds more stocks than 34% of peers
Cash
7%
Holds more cash than 7% of peers
Holdings in August 2025
Download CSVEvery line the fund disclosed, with the change against Jul 2025. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 11.94%
- Δ weight
- down 0.28 pts
- Value
- ₹998 Cr
- Δ value
- down ₹70.2 Cr
- Status
- Trimmed
- Weight
- 7.34%
- Δ weight
- down 0.21 pts
- Value
- ₹613 Cr
- Δ value
- down ₹46.4 Cr
- Status
- Trimmed
- Weight
- 6.09%
- Δ weight
- up 0.39 pts
- Value
- ₹509 Cr
- Δ value
- up ₹11.1 Cr
- Status
- Added
- Weight
- 6.09%
- Δ weight
- up 0.16 pts
- Value
- ₹509 Cr
- Δ value
- down ₹9.2 Cr
- Status
- Trimmed
- Weight
- 5.91%
- Δ weight
- up 0.34 pts
- Value
- ₹494 Cr
- Δ value
- up ₹7.3 Cr
- Status
- Added
- Weight
- 5.90%
- Δ weight
- up 0.21 pts
- Value
- ₹493 Cr
- Δ value
- down ₹4 Cr
- Status
- Trimmed
- Weight
- 3.65%
- Δ weight
- down 0.21 pts
- Value
- ₹305 Cr
- Δ value
- down ₹32.1 Cr
- Status
- Trimmed
- Weight
- 3.48%
- Δ weight
- down 0.07 pts
- Value
- ₹291 Cr
- Δ value
- down ₹19.4 Cr
- Status
- Trimmed
- Weight
- 3.04%
- Δ weight
- down 0.26 pts
- Value
- ₹254 Cr
- Δ value
- down ₹34.5 Cr
- Status
- Trimmed
- Weight
- 2.96%
- Δ weight
- down 0.16 pts
- Value
- ₹247 Cr
- Δ value
- down ₹25.5 Cr
- Status
- Trimmed
- Weight
- 2.84%
- Δ weight
- down 0.18 pts
- Value
- ₹238 Cr
- Δ value
- down ₹26.3 Cr
- Status
- Trimmed
- Weight
- 2.63%
- Δ weight
- down 0.01 pts
- Value
- ₹219 Cr
- Δ value
- down ₹10.5 Cr
- Status
- Trimmed
- Weight
- 2.59%
- Δ weight
- down 0.12 pts
- Value
- ₹216 Cr
- Δ value
- down ₹20.1 Cr
- Status
- Trimmed
- Weight
- 2.52%
- Δ weight
- up 0.16 pts
- Value
- ₹211 Cr
- Δ value
- up ₹4.2 Cr
- Status
- Added
- Weight
- 2.41%
- Δ weight
- up 0.03 pts
- Value
- ₹202 Cr
- Δ value
- down ₹6.1 Cr
- Status
- Trimmed
- Weight
- 2.35%
- Δ weight
- up 0.13 pts
- Value
- ₹196 Cr
- Δ value
- up ₹2.3 Cr
- Status
- Added
- Weight
- 2.24%
- Δ weight
- up 0.01 pts
- Value
- ₹187 Cr
- Δ value
- down ₹7.3 Cr
- Status
- Trimmed
- Weight
- 2.16%
- Δ weight
- down 0.10 pts
- Value
- ₹181 Cr
- Δ value
- down ₹16.6 Cr
- Status
- Trimmed
- Weight
- 2.09%
- Δ weight
- down 0.13 pts
- Value
- ₹175 Cr
- Δ value
- down ₹19.1 Cr
- Status
- Trimmed
- Weight
- 2.06%
- Δ weight
- up 0.04 pts
- Value
- ₹172 Cr
- Δ value
- down ₹4.5 Cr
- Status
- Trimmed
- Weight
- 2.05%
- Δ weight
- up 0.19 pts
- Value
- ₹172 Cr
- Δ value
- up ₹8.8 Cr
- Status
- Added
- Weight
- 1.96%
- Δ weight
- up 0.07 pts
- Value
- ₹164 Cr
- Δ value
- down ₹1.2 Cr
- Status
- Trimmed
- Weight
- 1.76%
- Δ weight
- down 0.01 pts
- Value
- ₹147 Cr
- Δ value
- down ₹7.5 Cr
- Status
- Trimmed
- Weight
- 1.42%
- Δ weight
- down 0.12 pts
- Value
- ₹118 Cr
- Δ value
- down ₹15.7 Cr
- Status
- Trimmed
- Weight
- 1.39%
- Δ weight
- up 0.05 pts
- Value
- ₹116 Cr
- Δ value
- down ₹1 Cr
- Status
- Trimmed
- Weight
- 1.33%
- Δ weight
- up 0.13 pts
- Value
- ₹111 Cr
- Δ value
- up ₹5.9 Cr
- Status
- Added
- Weight
- 1.30%
- Δ weight
- down 0.02 pts
- Value
- ₹109 Cr
- Δ value
- down ₹7 Cr
- Status
- Trimmed
- Weight
- 1.29%
- Δ weight
- down 0.01 pts
- Value
- ₹108 Cr
- Δ value
- down ₹5.5 Cr
- Status
- Trimmed
- Weight
- 1.20%
- Δ weight
- up 0.12 pts
- Value
- ₹101 Cr
- Δ value
- up ₹6 Cr
- Status
- Added
- Weight
- 1.04%
- Δ weight
- up 0.12 pts
- Value
- ₹86.6 Cr
- Δ value
- up ₹6.2 Cr
- Status
- Added
- Weight
- 0.96%
- Δ weight
- down 0.09 pts
- Value
- ₹80.1 Cr
- Δ value
- down ₹11.3 Cr
- Status
- Trimmed
- Weight
- 0.82%
- Δ weight
- down 0.08 pts
- Value
- ₹68.8 Cr
- Δ value
- down ₹9.8 Cr
- Status
- Trimmed
- Weight
- 0.78%
- Δ weight
- up 0.03 pts
- Value
- ₹65.5 Cr
- Δ value
- down ₹76 L
- Status
- Trimmed
- Weight
- 0.63%
- Δ weight
- down 0.02 pts
- Value
- ₹52.9 Cr
- Δ value
- down ₹4.5 Cr
- Status
- Trimmed
- Weight
- 0.59%
- Δ weight
- down 0.08 pts
- Value
- ₹48.9 Cr
- Δ value
- down ₹9.4 Cr
- Status
- Trimmed
- Cash, TREPS & receivables
- Weight
- 0.52%
- Δ weight
- down 0.03 pts
- Value
- ₹43.4 Cr
- Δ value
- down ₹4.4 Cr
- Status
- Trimmed
- Weight
- 0.43%
- Δ weight
- up 0.02 pts
- Value
- ₹36.2 Cr
- Δ value
- down ₹31 L
- Status
- Trimmed
- Weight
- 0.22%
- Δ weight
- down <0.01 pts
- Value
- ₹18.8 Cr
- Δ value
- down ₹96 L
- Status
- Trimmed
What changed, Jul 2025 to Aug 2025
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Cipla Limitedup ₹11.1 Cr (+0.39% pts)
- Alkem Laboratories Limitedup ₹8.8 Cr (+0.19% pts)
- Apollo Hospitals Enterprise Limitedup ₹7.3 Cr (+0.34% pts)
- Anthem Biosciences Limitedup ₹6.2 Cr (+0.12% pts)
- Fortis Healthcare Limitedup ₹6 Cr (+0.12% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Jul 2025, the weight rose most in Healthcare Services (+0.3 pts), and fell most in Retailing (−0.2 pts).
- Healthcare Services20.0% → 20.2%+0.3 pts
- Retailing3.9% → 3.7%−0.2 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Aug 2022 | Aug 2024 | Feb 2025 | May 2025 | Jul 2025 | Aug 2025 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 80.6% | 79.0% | 78.3% | 75.8% | 75.5% | 75.5% |
| Healthcare Services | 17.4% | 17.7% | 17.7% | 19.4% | 20.0% | 20.2% |
| Retailing | — | 2.5% | 3.4% | 4.3% | 3.9% | 3.7% |
| Pharmaceuticals | 1.4% | 0.8% | 0.5% | 0.6% | 0.7% | 0.6% |
Allocation in Aug 2025change vs Jul 2025
- Pharmaceuticals & Biotechnology (27)75.5%
- Healthcare Services (8)20.2%▲ 0.3 pts
- Retailing (1)3.7%▼ 0.2 pts
- Pharmaceuticals (1)
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Aug 2025
0.5%
unchanged vs Jul 2025
- Cash alone
- 0.5%
- cash and net receivables
- A year earlier
- 2.6%
- Aug 2024 · now ▼ 2.1 pts
- Last 12 months
- 0.3% – 4.4%
- lowest to highest · record 5.9% in May 2021
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.